Prof. Dr. B. Manger

Publikationen: Prof. Dr. med. B. Manger

Tausche AK, Schneidereit T, Napierala H, Reuß-Borst M, Klemm P, Clausen J, Morf H, Truthmann J, Karl I, Engel B, Keyßer G, Müller-Ladner U, Kettritz R, Kielstein J, Makowski M, Booz C, Carl HD, Gaulke R, Adam O, Michalsen A, Fritsch M, Alten R, Manger B, Krüger K, Schmidt WA, Schwarting A, Braun J, Kiltz U:[Diagnostics and treatment of gout : S3 guideline of the German Society for Rheumatology and Clinical Immunology (DGRh, lead management) and participating professional societies: German Society for Internal Medicine (DGIM), German Society for General Medicine and Family Medicine (DEGAM), German Society for Nephrology (DGfN), German Society for Orthopaedic and Trauma Surgery (DGOU), German Society for Nutritional Medicine (DGEM), German Roentgen Society-Society for Medical Radiology (DRG), German Rheumatism League].Z Rheumatol. 2025;84(Suppl 2): 51-81
Tausche AK, Schneidereit T, Napierala H, Reuß-Borst M, Klemm P, Clausen J, Morf H, Truthmann J, Karl I, Engel B, Keyßer G, Müller-Ladner U, Kettritz R, Kielstein J, Makowski M, Booz C, Carl HD, Gaulke R, Adam O, Michalsen A, Fritsch M, Alten R, Manger B, Krüger K, Schmidt WA, Schwarting A, Braun J, Kiltz U:[Diagnostics and treatment of gout : Short version of the German S3 guideline].Z Rheumatol. 2025;84(6): 471-493
Beyer C, Ganslmayer M, Strauß R, Manger B:Clinical Images: Sevoflurane-induced periostitis.Arthritis Rheumatol. 2025;():
Yalcin Mutlu M, Kleyer A, Kroenke G, Fagni F, Temiz SA, Meder C, Dietrich P, Orlemann T, Mößner J, Schoenau V, Bohr D, Schuster L, Hartmann F, Minopoulou I, Leppkes M, Ramming A, Pachowsky ML, Schuch F, Ronneberger M, Kleinert S, Hueber AJ, Manger K, Manger B, Atreya R, Berking C, Sticherling M, Neurath MF, Schett G, Simon D, Tascilar K:Paucity of viral infection symptoms in patients with immune-mediated inflammatory diseases.BMJ Open. 2025;15(1):
Rech J, Tascilar K, Hagen M, Kleyer A, Manger B, Schoenau V, Hueber AJ, Kleinert S, Baraliakos X, Braun J, Kiltz U, Fleck M, Rubbert-Roth A, Kofler DM, Behrens F, Feuchtenberger M, Zaenker M, Voll R, Venhoff N, Thiel J, Glaser C, Feist E, Burmester GR, Karberg K, Strunk J, Cañete JD, Senolt L, Filkova M, Naredo E, Largo R, Krönke G, D'Agostino MA, Østergaard M, Schett G:Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.Lancet. 2024;403(10429): 850-859
Manger B, Schett G:Bessel's disease-the first report of an IgG4-related disorder.Z Rheumatol. 2024;83(8): 661-663
Manger B, Schett G:Magnesium Disorders.N Engl J Med. 2024;391(7): 668-669
Pauly M, Rech J, Blank N, Ramming A, Hagen M, Wacker J, Manger B, Rech D, Hueber A, Kaudewitz D, Reis A, Hueffmeier U:VEXAS syndrome - expanding the phenotypic spectrum of this underdiagnosed disorder in rheumatology and hematologyEur J Hum Genet. 2024;32 Suppl 2(): 1430-1431
Schmalzing M, Sander O, Seidl M, Marks R, Blank N, Kötter I, Tiemann M, Backhaus M, Manger B, Hübel K, Müller-Ladner U, Henes J:Castleman's disease in the rheumatological practice.Z Rheumatol. 2024;83(Suppl 3): 289-298
Minopoulou I, Tascilar K, Corte G, Mutlu MY, Schmidt K, Bohr D, Hartmann F, Manger K, Manger B, Korn K, Kleyer A, Simon D, Harrer T, Schett G, Fagni F:Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study.Rheumatology (Oxford). 2024;63(5): 1377-1383
Schuster L, Valor-Méndez L, Wacker J, Dannhardt-Thiem V, Schmidt A, Knitza J, Simon D, Manger B, Schett G, Kleyer A:["Rheuma (be-)greifen"- A multimodal teaching concept to improve rheumatology education for medical students].Z Rheumatol. 2024;83(3): 186-193
Proft F, die Kommission Fort- und Weiterbildung der Deutschen Gesellschaft für Rheumatologie , Vossen D, Baraliakos X, Berliner MN, Fleck M, Keyßer G, Krause A, Lorenz HM, Manger B, Schuch F, Specker C, Wollenhaupt J, Voormann A, Raspe M, Krusche M, Pfeil A:[Survey on the working, training, and research conditions of resident physicians in internistic and rheumatological continuing education-BEWUSST].Z Rheumatol. 2024;83(4): 257-268
Schmalzing M, Sander O, Seidl M, Marks R, Blank N, Koetter I, Tiemann M, Backhaus M, Manger B, Huebel K, Mueller-Ladner U, Henes J:[Castleman's disease in the rheumatological practice].Z Rheumatol. 2024;83(4): 316-326
Proft F, Vossen D, Baraliakos X, Berliner MN, Fleck M, Keyßer G, Krause A, Lorenz HM, Manger B, Schuch F, Specker C, Wollenhaupt J, Voormann A, Raspe M, Krusche M, Pfeil A, Kommission Fort- und Weiterbildung der Deutschen Gesellschaft für Rheumatologie:Survey on the working, training, and research conditions of resident physicians in internistic and rheumatological continuing education-BEWUSST.Z Rheumatol. 2024;83(Suppl 1): 31-39
Valor-Méndez L, Atzinger A, Reis P, Manger B, Schett G:Clinical Images: Increased bone metabolism in secondary hyperparathyroidism.Arthritis Rheumatol. 2023;75(6):
Yalcin Mutlu M, Wacker J, Tascilar K, Taubmann J, Manger B, Krönke G, Schett G, Simon D:Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance.Rheumatology (Oxford). 2023;62(2): e21-e23
Stephan M, Tascilar K, Yalcin-Mutlu M, Hagen M, Haschka J, Reiser M, Hartmann F, Kleyer A, Hueber AJ, Manger B, Figueiredo C, Cobra JF, Tony HP, Finzel S, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nüsslein H, Alten R, Henes J, Krüger K, Schett G, Rech J:Physical Function of RA patients Tapering Treatment-A Post Hoc Analysis of the Randomized Controlled RETRO Trial.J Clin Med. 2023;12(11):
Müller F, Boeltz S, Knitza J, Aigner M, Völkl S, Kharboutli S, Reimann H, Taubmann J, Kretschmann S, Rösler W, Manger B, Wacker J, Mougiakakos D, Jabari S, Schröder R, Uder M, Roemer F, Krönke G, Mackensen A, Schett G:CD19-targeted CAR T cells in refractory antisynthetase syndrome.Lancet. 2023;401(10379): 815-818
Valor-Méndez L, Türk M, Schett G, Manger B, Knitza J:Misdiagnosis of polymyositis in a young female patient with occult limb-girdle muscular dystrophy.Rheumatol Adv Pract. 2023;7(2):
Minopoulou I, Tascilar K, Corte G, Mutlu MY, Schmidt K, Bohr D, Hartmann F, Manger B, Kleyer A, Simon D, Harrer T, Schett G, Fagni F:Tixagevimab/Cilgavimab for the Prevention of COVID-19 in Vaccine-refractory Patients with Autoimmune Diseases: A Prospective Cohort StudyArthritis Rheumatol. 2023;75 Suppl 9(): 3578-3581
Schaefer M, Meissner Y, Manger B, Berger S, Rockwitz K, Regierer A, Strangfeld A:Incident Malignancies in Patients with Rheumatoid Arthritis in Daily Rheumatological CareArthritis Rheumatol. 2023;75 Suppl 9(): 3238-3240
Pfeil A, Krusche M, Proft F, Vossen D, Braun J, Baraliakos X, Berliner MN, Keyßer G, Krause A, Lorenz HM, Manger B, Schuch F, Specker C, Wollenhaupt J, Voormann A, Fleck M:[Rheumatology training positions in Germany].Z Rheumatol. 2023;82(7): 539-551
Simon D, Tascilar K, Kleyer A, Fagni F, Krönke G, Meder C, Dietrich P, Orlemann T, Kliem T, Mößner J, Liphardt AM, Schönau V, Bohr D, Schuster L, Hartmann F, Leppkes M, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Hueber AJ, Manger K, Manger B, Atreya R, Berking C, Sticherling M, Neurath MF, Schett G:Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort.Arthritis Rheumatol. 2022;74(5): 783-790
Simon D, Tascilar K, Fagni F, Kleyer A, Krönke G, Meder C, Dietrich P, Orlemann T, Mößner J, Taubmann J, Mutlu MY, Knitza J, Kemenes S, Liphardt AM, Schönau V, Bohr D, Schuster L, Hartmann F, Minopoulou I, Leppkes M, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Hueber AJ, Manger K, Manger B, Atreya R, Berking C, Sticherling M, Neurath MF, Schett G:Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study.Lancet Rheumatol.. 2022;4(9): e614-e625
Valor-Méndez L, Dorn C, Manger B, Schett G, Kleyer A:Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator.Rheumatol Adv Pract. 2022;6(3):
Yalcin Mutlu M, Taubmann J, Wacker J, Tascilar K, Fagni F, Gerner M, Klett D, Schett G, Manger B, Simon D:Neutralizing monoclonal antibodies against SARS-CoV-2 for COVID-19 pneumonia in a rituximab treated patient with systemic sclerosis-A case report and literature review.Front Med (Lausanne). 2022;9():
Fagni F, Schmidt K, Bohr D, Valor-Méndez L, Hartmann F, Tascilar K, Manger K, Manger B, Kleyer A, Simon D, Schett G, Harrer T:Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination.RMD Open. 2022;8(1):
Valor-Méndez L, Manger B, Winterholler M, Schett G, Türk M, Knitza J:Rare meets rarer: anti-synthetase syndrome in a patient with facio-scapulo-humeral muscular dystrophy.Rheumatology (Oxford). 2022;61(12): e368-e370
Valor-Méndez L, Manger B, Wacker J, Kleyer A, Schett G:Lymph node and pulmonary tuberculosis during upadacitinib treatment in a psoriatic arthritis patient.Rheumatol Adv Pract. 2022;6(2):
Schulz SR, Hoffmann M, Roth E, Pracht K, Burnett DL, Mazigi O, Schuh W, Manger B, Mielenz D, Goodnow CC, Christ D, Pöhlmann S, Jäck HM:Augmented neutralization of SARS-CoV-2 Omicron variant by boost vaccination and monoclonal antibodies.Eur J Immunol. 2022;52(6): 970-977
Valor-Méndez L, Manger B, Knitza J, Schmidkonz C, Kleyer A, Schett G:Clinical Images: Tissue remodeling in autoimmune statin-induced necrotizing autoimmune myopathy.ACR Open Rheumatol. 2022;4(10): 835-836
Valor-Méndez L, Wacker J, Schett G, Manger B, Fürst J, Strauß R, Kleyer A:Clinical Images: Voriconazole-induced synovitis, enthesitis, and periostitis.Arthritis Rheumatol. 2022;74(7):
Manger B, Manger K:Pseudoacrocyanosis: a case for telemedicine in rheumatology.RMD Open. 2022;8(2):
Müller-Ladner U, Manger B:[The rubric "Pioneers of rheumatology" becomes "Milestones of rheumatology"].Z Rheumatol. 2022;81(2): 145-146
Kiltz U, Buschhorn-Milberger V, Albrecht K, Lakomek HJ, Lorenz HM, Rudwaleit M, Schneider M, Schulze-Koops H, Aringer M, Hasenbring MI, Herzer P, von Hinüber U, Krüger K, Lauterbach A, Manger B, Oltman R, Schuch F, Schmale-Grede R, Späthling-Mestekemper S, Zinke S, Braun J:[Development of quality standards for patients with rheumatoid arthritis for use in Germany].Z Rheumatol. 2022;81(9): 744-759
Simon D, Tascilar K, Fagni F, Schmidt K, Krönke G, Kleyer A, Ramming A, Schoenau V, Bohr D, Knitza J, Harrer T, Manger K, Manger B, Schett G:Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease.Ann Rheum Dis. 2022;81(7): 1023-1027
Valor-Méndez L, Schett G, Manger B:Treatment of refractory hypocomplementaemic urticarial vasculitis syndrome progressing to systemic lupus erythematosus with belimumab.Clin Exp Rheumatol. 2022;40(4): 854-855
Simon D, Tascilar K, Schmidt K, Manger B, Weckwerth L, Sokolova M, Bucci L, Fagni F, Manger K, Schuch F, Ronneberger M, Hueber A, Steffen U, Mielenz D, Herrmann M, Harrer T, Kleyer A, Krönke G, Schett G:Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion.Arthritis Rheumatol. 2022;74(1): 33-37
Wagner N, Manger B, Kittler J, Rech J, Sticherling M, Berking C, Kirchberger MC:Three generations of suffering: cryopyrin-associated periodic syndrome with NLRP3 mutation in a family.J Dtsch Dermatol Ges. 2022;20(1): 110-112
Fagni F, Schmidt K, Bohr D, Mendez LV, Minopoulou I, Mutlu MY, Hartmann F, Tascilar K, Manger K, Manger B, Kleyer A, Simon D, Schett G, Harrer T:Pre-exposure Prophylaxis for SARS-CoV-2 with Subcutaneous Casirivimab/Imdevimab in Vaccine-refractory Patients with Immune-mediated Inflammatory DiseasesArthritis Rheumatol. 2022;74 Suppl 9(): 4351-4352
Arora P, Zhang L, Rocha C, Sidarovich A, Kempf A, Schulz S, Cossmann A, Manger B, Baier E, Tampe B, Moerer O, Dickel S, Dopfer-Jablonka A, Jäck HM, Behrens GMN, Winkler MS, Pöhlmann S, Hoffmann M:Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3.Lancet Infect Dis. 2022;22(6): 766-767
Pfeil A, Krusche M, Vossen D, Berliner MN, Keyßer G, Krause A, Lorenz HM, Manger B, Schuch F, Specker C, Wollenhaupt J, Baraliakos X, Fleck M, Proft F:Model curriculum of the German society for Rheumatology for advanced training in the discipline internal medicine and rheumatology. English version.Z Rheumatol. 2021;80(Suppl 2): 64-67
Pfeil A, Krusche M, Vossen D, Berliner MN, Keyßer G, Krause A, Lorenz HM, Manger B, Schuch F, Specker C, Wollenhaupt J, Baraliakos X, Fleck M, Proft F:[Model curriculum of the German Society for Rheumatology for advanced training in the discipline internal medicine and rheumatology].Z Rheumatol. 2021;80(7): 688-691
Strangfeld A, Manger B, Worsch M, Schmeiser T, Zink A, Schaefer M:ELDERLY PATIENTS ARE NOT AT INCREASED RISK OF SERIOUS INFECTIONS WHEN RECEIVING BDMARDS OR JAK INHIBITORS COMPARED TO CSDMARD TREATMENTAnn Rheum Dis. 2021;80 Suppl 1(): 64-65
Kalden JR, Manger B:About the Development of clinical Rheumatology in the Federal Republic of Germany after World War IIAktuelle Rheumatol. 2021;46(03): 241-242
Kleyer A, Roemer F, Schett G, Manger B:Differenzialdiagnose Ruckenschmerzen mit Entzundungsparametern: Fallvorstellung: Manifestation einer CPPD als Crowned Dens Syndrom mit Befall peripherer GelenkeAktuelle Rheumatol. 2021;46(01): 76-79
Schenker HM, Hagen M, Simon D, Schett G, Manger B:Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection.Rheumatology (Oxford). 2021;60(1): 479-480
Manger B, Schett G, Burmester GR:Johann Lucas Schoenlein (1793-1864): impact without publicationsAnn Rheum Dis. 2021;80(2): 140-142
Valor-Méndez L, Kleyer A, Rech J, Manger B, Schett G:Long-term B-lymphocyte depletion and remission of granulomatosis with polyangiitis after two courses of rituximab treatment.Rheumatology (Oxford). 2021;60(5): e162-e164
Vodencarevic A, Tascilar K, Hartmann F, Reiser M, Hueber AJ, Haschka J, Bayat S, Meinderink T, Knitza J, Mendez L, Hagen M, Krönke G, Rech J, Manger B, Kleyer A, Zimmermann-Rittereiser M, Schett G, Simon D, RETRO study group:Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs.Arthritis Res Ther. 2021;23(1):
Simon D, Tascilar K, Fagni F, Krönke G, Kleyer A, Meder C, Atreya R, Leppkes M, Kremer AE, Ramming A, Pachowsky ML, Schuch F, Ronneberger M, Kleinert S, Hueber AJ, Manger K, Manger B, Berking C, Sticherling M, Neurath MF, Schett G:SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases.Ann Rheum Dis. 2021;80(10): 1312-1316
Morf H, Roemer F, Agaimy A, Schett G, Manger B:IgG4-related fasciitis.Rheumatology (Oxford). 2021;61(1): e11-e12
Schönau V, Roth J, Tascilar K, Corte G, Manger B, Rech J, Schmidt D, Cavallaro A, Uder M, Crescentini F, Boiardi L, Casali M, Spaggiari L, Galli E, Kuwert T, Versari A, Salvarani C, Schett G, Muratore F:Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study.Rheumatology (Oxford). 2021;60(8): 3851-3861
Schälter F, Dürholz K, Bucci L, Burmester G, Caporali R, Figuereido C, Cobra JF, Manger B, Zaiss MM, Schett G:Does methotrexate influence COVID-19 infection? Case series and mechanistic data.Arthritis Res Ther. 2021;23(1):
Valor-Méndez L, Kleyer A, Rech J, Manger B, Schett G:Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis.Auto Immun Highlights. 2021;12(1):
Valor-Méndez L, Manger B, Cavallaro A, Achenbach S, Schett G, Rech J:Autoinflammation leading to autoimmunity in adult-onset Still's disease: more than simple coincidence?Eur J Med Res. 2021;26(1):
Valor-Méndez L, Kleyer A, Schett G, Manger B, Sticherling M:Contrary immediate effect of abatacept on skin and joint manifestations in psoriatic arthritis.Rheumatology (Oxford). 2021;60(9): e312-e313
Valor-Méndez L, Manger B, Schett G, Kleyer A:[Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib].Z Rheumatol. 2021;80(10): 980-983
Mougiakakos D, Krönke G, Völkl S, Kretschmann S, Aigner M, Kharboutli S, Böltz S, Manger B, Mackensen A, Schett G:CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.N Engl J Med. 2021;385(6): 567-569
Schett G, Kalden JR, Manger B:[80 milestones in rheumatology from 80 years. II. 1961-1980].Z Rheumatol. 2021;80(6): 506-514
Manger B, Schett G:[80 milestones in rheumatology from 80 years- I. 1940-1960].Z Rheumatol. 2021;80(6): 497-505
Hagen M, Tascilar K, Reiser M, Valor L, Haschka J, Kleyer A, Hueber A, Manger B, Cobra J, Figuereido C, Finzel S, Tony HP, Wendler J, Kleinert S, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Alten R, Henes J, Krueger K, Rech J, Schett G:TREATMENT TAPERING AND WITHDRAWAL IN RHEUMATOID ARTHRITIS WITH STABLE REMISSION - FINAL ANALYSIS OF THE RETRO STUDYAnn Rheum Dis. 2021;80 Suppl 1(): 194-195
Burmester GR, Manger B, Schett G, Schulze-Koops H:Joachim Robert Kalden: one of the founders of autoimmunity research and immunotherapyAnn Rheum Dis. 2021;80(6): 682-684
Tascilar K, Hagen M, Kleyer A, Simon D, Reiser M, Hueber AJ, Manger B, Englbrecht M, Finzel S, Tony HP, Schuch F, Kleinert S, Wendler J, Ronneberger M, Figueiredo CP, Cobra JF, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Kruger K, Henes J, Schett G, Rech J:Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trialLancet Rheumatol.. 2021;3(11): E767-E777
Dross F, Manger B, Teichfischer P:The Treasure in the Attic Johann Lukas Schonlein's Correspondence EstateMedizinhist J. 2021;56(4): 326-341
Schmidkonz C, Rauber S, Atzinger A, Agarwal R, Götz TI, Soare A, Cordes M, Prante O, Bergmann C, Kleyer A, Ritt P, Maschauer S, Hennig P, Toms J, Köhner M, Manger B, Stone JH, Haberkorn U, Baeuerle T, Distler JHW, Agaimy A, Kuwert T, Schett G, Ramming A:Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging.Ann Rheum Dis. 2020;79(11): 1485-1491
Valor-Méndez L, Hagen M, Kleyer A, Manger B, Schett G:Massive nodulous lesions on hands and feet in a RA patient and improvement under baricitinib treatment.RMD Open. 2020;6(3):
Simon D, Tascilar K, Kronke G, Kleyer A, Zaiss M, Heppt F, Meder C, Atreya R, Klenske E, Dietrich P, Abdullah A, Kliem T, Corte G, Morf H, Leppkes M, Kremer A, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Maier C, Hueber A, Manger K, Manger B, Berking C, Tenbusch M, Ueberla K, Sticherling M, Neurath M, Schett G:Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 InfectionArthritis Rheumatol. 2020;72 Suppl 10():
Knitza J, Schett G, Manger B:Rheumatic Paraneoplastic SyndromesAktuelle Rheumatol. 2020;45(06): 531-534
Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss MM, Heppt F, Meder C, Atreya R, Klenske E, Dietrich P, Abdullah A, Kliem T, Corte G, Morf H, Leppkes M, Kremer AE, Ramming A, Pachowsky M, Schuch F, Ronneberger M, Kleinert S, Maier C, Hueber AJ, Manger K, Manger B, Berking C, Tenbusch M, Überla K, Sticherling M, Neurath MF, Schett G:Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion.Nat Commun. 2020;11(1):
Kleyer A, Knitza J, Schett G, Manger B:Calcium pyrophosphate deposition disease induced inflammatory back pain.Rheumatology (Oxford). 2020;59(2): 456-456
Schett G, Manger B, Simon D, Caporali R:COVID-19 revisiting inflammatory pathways of arthritis.Nat Rev Rheumatol. 2020;16(8): 465-470
Schäfer M, Meißner Y, Kekow J, Berger S, Remstedt S, Manger B, Listing J, Strangfeld A, Zink A:Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis.Rheumatology (Oxford). 2020;59(8): 1916-1926
Schäfer M, Meißner Y, Kekow J, Berger S, Remstedt S, Manger B, Listing J, Strangfeld A, Zink A:Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis.Rheumatology (Oxford). 2020;59(8): 2191-2191
Koutzamanidis R, Mentzer D, Knauss S, Broeckelmann PJ, Hassel JC, Ugurel-Becker S, Pavel M, Nickel F, Landendinger M, Fuchs F, Meidenbauer N, Jefremow A, Manger B, Gutzmer R, Loguai C, Kaehler K, Zimmer L, Berking C, Keller-Stanislawski B, Heinzerling L, Erdrnann M, Kirchberger MC, Toussaint F:Serio - Side Effect Registry in Immuno-OncologyOncology Research and Treatment. 2020;43(): 231-231
Rudi T, Schaefer M, Manger B, Zink A, Strangfeld A:NO INCREASED RISK OF FALLS IN PATIENTS TREATED WITH BIOLOGICS COMPARED TO THOSE UNDER CSDMARDSAnn Rheum Dis. 2020;79 Suppl 1(): 974-974
Kramer R, Mentzer D, Erdmann M, Knauss S, Broeckelmann PJ, Hassel JC, Ugurel S, Pavel M, Nickel FT, Landendinger M, Fuchs F, Meidenbauer N, Jefremow A, Manger B, Gutzmer R, Loquai C, Kaehler K, Zimmer L, Berking C, Keller-Stanislawski B, Heinzerling L:SERIO - Side Effect Registry Immuno-Oncology Side Effect Registry for rare, severe and complex Side Effects of ImmunotherapyJ Dtsch Dermatol Ges. 2020;18 Suppl 2(): 14-15
Ellmann H, Bayat S, Araujo E, Manger B, Kleyer A, Cavallaro A, Lell M, Schenker H, Simon D, Tascilar K, Baraf HSB, Schett G, Rech J:Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal DepositsArthritis Rheumatol. 2020;72(1): 150-156
Manger B:Hypophosphatasia is associated with nonspecific SymptomsZ Rheumatol. 2019;78(6): 496-496
Manger B:Rheumatologic Manifestations of HemoglobinopathiesZ Rheumatol. 2019;78(6): 496-496
Baerwald C, Manger B, Hueber A:Depression as comorbidity of rheumatoid arthritisZ Rheumatol. 2019;78(3): 243-248
Strangfeld A, Krueger K, Manger B, Kneitz C, Zink A, Schaefer M:NO DIFFERENCE IN TREATMENT CONTINUATION OF DIFFERENT BIOLOGICS IN ELDERLY PATIENTS > 70 YEARS COMPARED TO YOUNGER PATIENTS <= 65 YEARSAnn Rheum Dis. 2019;78(): 1123-1123
Andes F, Zapf J, Hahn J, Manger B, Schett G, Steffen U:HIGHER EXPRESSION OF SIGLEC-7/9 ON GRANULOCYTES AND MONOCYTES HAS A PROTECTIVE ROLE IN RHEUMATOID ARTHRITISAnn Rheum Dis. 2019;78(): A65-A66
Knitza J, Kampylafka E, Wacker J, Schett G, Manger B:[Erdheim-Chester disease : An important differential diagnosis and its main symptoms].Z Rheumatol. 2019;78(1): 66-71
Stephan M, Tascilar K, Hagen M, Haschka J, Reiser M, Hartmann F, Kleyer A, Hueber A, Manger B, Figuereido C, Cobra J, Tony HP, Finzel S, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Henes J, Krueger K, Schett G, Rech J:PHYSICAL FUNCTION IN RA PATIENTS IN REMISSION UNDERGOING TAPERING AND/OR STOPPING OF DMARDSAnn Rheum Dis. 2019;78(): 321-322
Leavis H, Zwerina J, Manger B, Fritsch-Stork RDE:Novel Developments in Primary Immunodeficiencies (PID)-a Rheumatological PerspectiveCurr Rheumatol Rep. 2019;21(10):
Valor L, Hagen M, Reiser M, Hartmann F, Kleyer A, Manger B, Schett G, Rech J, Tascilar K:Factors Associated with Persistent Drug-free Remission in Patients with Rheumatoid ArthritisArthritis Rheumatol. 2019;71():
Hagen M, Tascilar K, Reiser M, Haschka J, Kleyer A, Valor L, Manger B, Schett G, Rech J:Prediction of Disease Relapses by Multi-biomarker Disease Activity Score and Autoantibody Status in RA Patients Tapering DMARD Treatment in Stable RemissionArthritis Rheumatol. 2019;71():
Bayat S, Ellmann H, Araujo E, Manger B, Hagen M, Kleyer A, Cavallaro A, Lell M, Schenker H, Simon D, Tascilar K, Baraf HSB, Schett G, Rech J:SIZE MATTERS - EXTENT OF MONOSODIUM URATE DEPOSITS BUT NOT SERUM URATE LEVEL PREDICTS COMPLETE RESOLUTION OF MONOSODIUM URATE CRYSTAL DEPOSITS IN PATIENTS WITH GOUTAnn Rheum Dis. 2019;78(): 1295-1296
Knitza J, Kleyer A, Schett G, Manger B:Chondrocalcinosis: idiopathic or manifestation of rare metabolic diseases?Orthopade. 2019;48(11): 949-956
Bursill D, Taylor WJ, Terkeltaub R, Abhishek A, So AK, Vargas-Santos AB, Gaffo AL, Rosenthal A, Tausche AK, Reginato A, Manger B, Scire C, Pineda C, van Durme C, Lin CT, Yin CC, Albert DA, Biernat-Kaluza E, Roddy E, Pascual E, Becce F, Perez-Ruiz F, Sivera F, Liote F, Schett G, Nuki G, Filippou G, McCarthy G, Castelar Pinheiro GDC, Ea HK, Tupinamba HD, Yamanaka H, Choi HK, Mackay J, ODell JR, Vazquez Mellado JV, Singh JA, Fitzgerald JD, Jacobsson LTH, Joosten L, Harrold LR, Stamp L, Andres M, Gutierrez M, Kuwabara M, Dehlin M, Janssen M, Doherty M, Hershfield MS, Pillinger M, Edwards NL, Schlesinger N, Kumar N, Slot O, Ottaviani S, Richette P, MacMullan PA, Chapman PT, Lipsky PE, Robinson P, Khanna PP, Gancheva RN, Grainger R, Johnson RJ, Te Kampe R, Keenan RT, Tedeschi SK, Kim S, Choi SJ, Fields TR, Bardin T, Uhlig T, Jansen T, Merriman T, Pascart T, Neogi T, Kluck V, Louthrenoo W, Dalbeth N:Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of goutAnn Rheum Dis. 2019;78(11): 1592-1600
Valor L, Hagen M, Reiser M, Kleyer A, Hartmann F, Manger B, Schett G, Rech J, Tascilar K, Haschka J, Englbrecht M, Hueber A, Figueiredo C, Fogagnolo J, Tony HP, Finzel S, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz HM, Nuesslein H, Alten R, Henes J, Krueger K, Retro:FACTORS ASSOCIATED WITH PERSISTENT DRUG-FREE REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITISAnn Rheum Dis. 2019;78(): 730-730
Strangfeld A, Krueger K, Manger B, Kneitz C, Zink A, Schaefer M:No Difference in Treatment Continuation of Different Biologics in Elderly Patients > 70 Years Compared to Younger Patients <= 65 YearsArthritis Rheumatol. 2019;71():
Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, Manger B, Figueiredo C, Cobra JF, Tony HP, Finzel S, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Lorenz HM, Nüsslein H, Alten R, Henes J, Krüger K, Schett G, Rech J:Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody Status.J Rheumatol. 2019;46(5): 460-466
Erhard J, Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber AJ, Manger B, Figueiredo C, Cobra JF, Tony HP, Finzel S, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Schmitt-Haendle M, Lorenz H, Nuesslein H, Alten R, Henes J, Krueger K, Schett G, Rech J:LOOSING DAS28-ESR, BUT STAYING IN BOOLEAN REMISSION-IS IT POSSIBLE? DATA FROM THE PROSPECTIVE, RANDOMISED RETRO TRIAL ON RHEUMATOID ARTHRITIS PATIENTS IN STABLE REMISSIONAnn Rheum Dis. 2018;77(): 1307-1308
Manger B, Schett G:Rheumatic paraneoplastic syndromes - A clinical link between malignancy and autoimmunity.Clin Immunol. 2018;186(): 67-70
Schönau V, Vogel K, Englbrecht M, Wacker J, Schmidt D, Manger B, Kuwert T, Schett G:The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study.Ann Rheum Dis. 2018;77(1): 70-77
Manger K, von Streitberg U, Seitz G, Kleyer A, Manger B:Hard palate hyperpigmentation-a rare side effect of antimalarials.Arthritis Rheumatol. 2018;70(1): 152
Hueber AJ, Schett G, Manger B:Unilateral plantar erythema nodosum in sarcoidosis.Arthritis Rheumatol. 2018;70(2):
Sauer EM, Schliep S, Manger B, Lee DH, Linker RA:Microscopic polyangiitis after alemtuzumab treatment in relapsing-remitting MS.Neurol Neuroimmunol Neuroinflamm. 2018;5(5):

Publikationen: Prof. Dr. med. B. Manger

Notfall

Notfallinformationen UKER

Patienten & Besucher

Ärzte & Zuweiser

Forschung

Lehre